Gritstone bio
Gritstone’s goal is to develop groundbreaking immunotherapies for cancers and infectious diseases. Our approach focuses on generating a therapeutic immune response in these patients by unleashing the natural power of a patient’s immune system to recognize and destroy tumors or virally infected cells.
Gritstone bio - Wikipedia
Gritstone bio is a clinical-stage American biotechnology company which develops cancer and infectious disease immunotherapies and vaccines. It was founded in August 2015 as Gritstone Oncology, Inc., and is based in Emeryville, California. In September 2021 it raised $55.0 million from the sale of 5,000,000 shares. [1]
Gritstone files for bankruptcy in hope of keeping R&D afloat
2024年10月10日 · Gritstone bio may have left no stone unturned when it came to searching for a financial rescue, but the vaccine biotech has decided that all roads now lead to bankruptcy.
Gritstone - Wikipedia
Gritstone or grit is a hard, coarse-grained, siliceous sandstone. This term is especially applied to such sandstones that are quarried for building material. British gritstone was used for millstones to mill flour, to grind wood into pulp for paper and for grindstones to sharpen blades.
About - Gritstone bio
Gritstone bio is developing next-generation vaccines for cancer and infectious disease. Gritstone’s approach seeks to generate potent and durable immune responses by leveraging insights into the immune system’s ability to recognize and destroy diseased cells by targeting select antigens.
Gritstone bio, Inc. (GRTSQ) Stock Price & Overview - Stock Analysis
4 天之前 · Get the latest Gritstone bio, Inc. (GRTSQ) stock price quote with financials, statistics, dividends, charts and more.
Our Pipeline - Gritstone bio
The companies are developing a curative HIV-specific therapeutic vaccine using Gritstone’s proprietary prime-boost vaccine platform, comprised of self-amplifying mRNA (samRNA) and adenoviral vectors.
Gritstone bio Announces Interim Phase 2 Data for GRANITE …
2024年9月30日 · Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines. We leverage our innovative vectors and payloads to train multiple arms of the immune system to attack critical disease targets.
Gritstone bio Announces Presentations from Phase 1 Studies …
EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today...
Nature Medicine Publishes Interim Results from ... - Gritstone bio
2024年4月15日 · Gritstone’s neoantigen-based vaccine programs, GRANITE (personalized) and SLATE (“off-the-shelf) are engineered to elicit a significant T cell response for patients with solid tumors.
- 某些结果已被删除